Lipoproteins, including LDL and HDL, play pivotal roles in cholesterol transport throughout the bloodstream. While LDL transports cholesterol to peripheral tissues, an excess can exacerbate atherogenesis. In contrast, HDL acts as a protective agent, extracting cholesterol from peripheral tissues and aiding in its disposal by the liver. Elevated levels of either LDL or triglycerides signal conditions like hyperlipoproteinemias or hyperlipidemias which can increase the risk of cardiovascular disease.
Statins act by inhibiting HMG-CoA reductase, an important enzyme involved in cholesterol synthesis. Statin therapy results in a dual benefit, leading to a marked reduction in cholesterol synthesis, as well as an upregulation of LDL receptors on hepatocytes that facilitates more effective LDL clearance. Additionally, statins have a mild effect on lowering triglyceride levels. Their cumulative impact on both LDL and triglycerides underscores their significance in cardiovascular protection, making them essential for patients with elevated risk profiles.
statins inhibit the liver enzyme HMG-CoA reductase, crucial for cholesterol production. This inhibition leads to a drop in cholesterol synthesis. Consequently, liver cells boost their LDL receptor numbers, enhancing LDL cholesterol uptake from the blood and lowering its levels in circulation.
statins, by lowering cholesterol, tackle the root cause of atherosclerosis‚Äîa buildup of cholesterol-rich plaques in arteries. These plaques can increase risks of heart attacks, strokes, and other cardiovascular ailments. By reducing cholesterol, statins effectively halt atherosclerosis advancement and the complications stemming from it.
Statins are generally well-tolerated, but side effects can occur. Notably, muscle-related issues range from discomfort to myopathy. In rare cases, myopathy may advance to rhabdomyolysis, causing severe muscle breakdown and kidney damage. Other potential side effects include elevated liver enzymes and digestive disturbances. These risks can increase with higher dosages and interactions with other drugs, especially those linked to the cytochrome P450 system.
LDL, often referred to as "bad" cholesterol, plays a significant role in the development of cardiovascular diseases. Statins target LDL by reducing its production in the liver, as well as promoting its clearance from the bloodstream. Statins are therefore linked with LDL reduction, and help to diminish the risk of atherosclerosis and other cardiovascular events.
Statins primarily act on the liver, where they reduce the production of cholesterol via inhibition of HMG-CoA reductase, an enzyme involved in cholesterol biosynthesis. Statins not only lower the overall cholesterol levels in the blood but also stimulate the liver to extract more cholesterol from the bloodstream, ensuring a more balanced cholesterol profile.